Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
de Boniface, Jana; Schmidt, Marcus; Engel, Jutta et al.
What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?BREAST CARE. Bd. 13. H. 5. 2018 S. 331-336
Roos, Wynand P.; Frohnapfel, Larissa; Quiros, Steve et al.
XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repairCANCER LETTERS. Bd. 424. 2018 S. 119-126
Singer, Susanne; Beckerle, Jutta; Kleining, Bernhard et al.
"The structures must be much more flexible". Qualitative survey of office-based psychotherapists on care of cancer patientsPSYCHOTHERAPEUT. Bd. 62. H. 5. 2017 S. 440-449
Merzenich, Hiltrud; Bartkowiak, Detlef; Schmidberger, Heinz et al.
3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)BREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 143-152
Hartmann, Ann-Kathrin; Lopez, Pamela Aranda; Zajac, Marek et al.
9-Phenanthrol enhances the generation of an CD8(+) T cell response following transcutaneous immunization with imiquimod in miceJOURNAL OF DERMATOLOGICAL SCIENCE. Bd. 87. H. 3. 2017 S. 260-267
Kelley, Robin Kate; Gane, Edward; Assenat, Eric et al.
A phase 2 study of galunisertib (TGF-B R1 inhibitor) and sorafenib in patients with advanced hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Thomssen, Christoph; Decker, Thomas; Fehm, Tanja et al.
A PHASE II STUDY OF METRONOMIC DAILY ORAL VINORELBINE AS FIRST-LINE CHEMOTHERAPY IN ADVANCED/METASTATIC HORMONE RECEPTOR POSITIVE (HR plus )/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE (HER2-) BREAST CANCER RESISTANT TO ENDOCRINE THERAPY: VINOMETROBREAST. Bd. 36. 2017 S. S51-S51
Harbeck, Nadia; Saupe, Steffen; Jaeger, Elke et al.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN studyBREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 63-72
Hajek, R.; Masszi, T.; Petrucci, M. T. et al.
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)LEUKEMIA. Bd. 31. H. 1. 2017 S. 107-114
Loibl, Sibylle; Barinoff, Jana; Seiler, Sabine et al.
A randomized, open-label, multicentre, phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy based treatment strategy in patients with hormone receptor positive/HER2-negative metastatic breast cancer in a real world settingJOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017